Left atrial thrombus and spontaneous echo-contrast in nonanticoagulated mitral stenosis. A transesophageal

C Vigna1, V de Rito, G M Criconia

  • 1Department of Cardiology, Ospedale Casa Sollievo della Sofferenza, IRCSC, San Giovanni Rotondo, Italy.

Chest
|February 1, 1993
PubMed

Insights

In nonanticoagulated mitral stenosis (MS), atrial fibrillation and left atrial (LA) size predict LA spontaneous echo-contrast (SEC). However, predicting LA thrombus requires transesophageal echocardiography (TEE) even with LA SEC.

Area of Science:

  • Cardiovascular Imaging
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Left atrial (LA) thrombus and spontaneous echo-contrast (SEC) are indicators of embolization risk in mitral stenosis (MS).
  • Predicting these findings using transthoracic echocardiography (TTE) can guide clinical decisions in nonanticoagulated patients.

Purpose of the Study:

  • To determine if clinical and TTE variables can predict LA thrombus and LA SEC in nonanticoagulated MS patients.
  • To assess the utility of TEE for detecting LA thrombus and LA SEC.

Main Methods:

  • Clinical data (age, NYHA class, rhythm, prior embolization) and TTE variables (mitral area, gradient, LA size, regurgitation) were collected.
  • Transesophageal echocardiography (TEE) was used to confirm LA thrombus and LA SEC.
  • Multivariate regression analysis identified predictors of LA thrombus and LA SEC.

Main Results:

  • LA thrombus was detected in 20.3% of patients, predominantly those with atrial fibrillation.
  • LA SEC was found in 67.8% of patients by TEE, significantly more than by TTE.
  • Atrial fibrillation and larger LA end-systolic area predicted both LA thrombus and LA SEC; smaller mitral area predicted LA SEC.
  • LA SEC was accurately predicted by atrial fibrillation and LA area ≥ 30 cm², but LA thrombus detection within the LA SEC group remained challenging without TEE.

Conclusions:

  • Transesophageal echocardiography (TEE) may not be routinely necessary for detecting LA spontaneous echo-contrast (SEC) in mitral stenosis (MS) patients.
  • TEE remains essential for definitive LA thrombus detection when clinically indicated for decision-making in MS patients.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for diagnosing...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...